Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication

31 Dec 2015

Abstract excerpt

Poliomyelitis has nearly been eradicated through the efforts of the World Health Organization's Global Eradication Initiative raising questions on containment of the virus after it has been eliminated in the wild. Most manufacture of inactivated polio vaccines currently requires the growth of large amounts of highly virulent poliovirus, and release from a production facility after eradication could be disastrous;...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Viral gastroenteritis research and epidemiology
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26720150
DOI: 10.1371/journal.ppat.1005316

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 15 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After EradicationPMID 26720150Read ↗

Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.Semantic proximity Read ↗

Attenuation and reversion of the Sabin vaccine strains of poliovirus.Semantic proximity Read ↗

Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to VirulenceSemantic proximity Read ↗

Genetically Thermo-Stabilised, Immunogenic Poliovirus Empty Capsids; a Strategy for Non-replicating VaccinesSemantic proximity Read ↗

Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.Semantic proximity Read ↗

Evolution and polymorphism of poliovirus genomes.Semantic proximity Read ↗

Developing genetically stable live-attenuated vaccine candidates against type 1 and 3 poliovirusSemantic proximity Read ↗

Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3Semantic proximity Read ↗

Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.Semantic proximity Read ↗

Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine virusesSemantic proximity Read ↗

Engineering attenuated virus vaccines by controlling replication fidelity.Semantic proximity Read ↗

Approaches to the construction of new candidate poliovirus type 3 vaccine strains.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.